E. Oravcová

444 citations

19 papers · 299 indexed · h-index 10

Impact in

Applied Microbiology and Biotechnology top 10%
- Antibiotic Use and Resistance
Infectious Diseases top 10%
- Antifungal resistance and susceptibility

Papers in

Clinical Biochemistry 7
- Bacterial Identification and Susceptibility Testing 7
Oncology 15
- Neutropenia and Cancer Infections 13
- Cancer Treatment and Pharmacology 2

Co-authors: S. Špánik J. Trupl E. Kukučková V. Krčméry A. Kunová Ľuboš Drgoňa Jozef Šufliarský P. Pichňa
Journals: Chemotherapy (3 papers)JAMA Oncology (1 paper)Journal of Clinical Oncology (1 paper)Infection (1 paper)Journal of Chemotherapy (1 paper)
Partner nations: Slovakia United States Malaysia

In The Last Decade

E. Oravcová

19 papers receiving 286 citations

Peers

Countries citing papers authored by E. Oravcová

Since Specialization

Citations

This map shows the geographic impact of E. Oravcová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Oravcová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Oravcová more than expected).

Fields of papers citing papers by E. Oravcová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Oravcová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Oravcová. The network helps show where E. Oravcová may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Oravcová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Oravcová Line = papers co-authored together E. Oravcová links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer JAMA Oncology ·Javier Cortés, Véronique Dièras, Sylvie Lorenzen, Filippo Montemurro, Jorge Riera‐Knorrenschild, Peter Thuss‐Patience, Giacomo Allegrini, Michelino De Laurentiis, Caroline Lohrisch, E. Oravcová, José Manuel Pérez-García, Francesco Ricci, Dina Sakaeva, Michael Montage, Jozef Šufliarský, María Vidal, Natsumi Irahara, H. A. Almahdi, Mounir Aout, Karen A. Gelmon	2020	35
2	Circulating tumor cells (CTCs) and epithelial mesenchymal transition (EMT) in primary breast cancer. Journal of Clinical Oncology ·Marián Karaba, Michal Mego, Gabriel Minárik, Juraj Benca, Tatiana Sedláčková, Virda Alya Novbira Mya, Kun Yuan, O. Mündel, S.W. Lee, Mingsong Chen, Metin Arslan, Paulina Gronesova, E. Oravcová, Abdul Rachmad Budiono, Jozef Šufliarský, Leung Ying Kit, James M. Reuben, Jozef Mardiak	2013	1
3	Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. PubMed ·Michal Mego, L. Ebringer, Ľuboš Drgoňa, Jozef Mardiak, J. Trupl, K. A. Murzina, 亮太麦山, E. Oravcová, Vladimír Zajac, I Koza	2005	25
4	Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome Journal of Antimicrobial Chemotherapy ·V. Krčméry, E. Oravcová, S. Špánik, M.U. Kim, J. Trupl, A. Kunová, Anton S. Mitin, E. Kukučková, Randall Lea, Helena Ruuska, Ph. Canton	1998	82
5	Fungemia in Cancer Patients Undergoing Chemotherapy Versus Surgery: Risk Factors, Etiology and Outcome Scandinavian Journal of Infectious Diseases ·Ph. Canton, S. Špánik, E. Oravcová, M Mrázová, Helen Jennings-Hood, Brian O Molokwu, E. Kukučková, Jiyu Zhang, P. Pichňa, Stéphanie Caroline Vaz Dias, A. Kunová, J. Trupl, V. Krčméry	1997	16
6	Risk Factors, Aetiology, Therapy and Outcome in 123 Episodes of Breakthrough Bacteraemia and Fungaemia during Antimicrobial Prophylaxis and Therapy in Cancer Patients Journal of Medical Microbiology ·S. Špánik, J. Trupl, A. Kunová, Ľuboš Drgoňa, (unknown), Jozef Mardiak, E. Kukučková, Л.І. Ружинська, P. Pichňa, E. Oravcová, Mina Araminejad, Jiyu Zhang, Joyce Cristina dos Santos Reis, Sandra Doherr, Jozef Šufliarský, V. Krčméry	1997	17
7	Viridans Streptococcal Bacteraemia Due to Penicillin-Resistant and Penicillin-Sensitive Streptococci: Analysis of Risk Factors and Outcome in 60 Patients from a Single Cancer Centre Before and After Penicillin is Used for Prophylaxis Scandinavian Journal of Infectious Diseases ·S. Špánik, J. Trupl, A. Kunová, Ma Pilar Sánchez, A.A-Z. Bytdaeva, Kevin H. Dunn, Л.І. Ружинська, Sandra Doherr, E. Oravcová, 信也二之宮, Leonardo Perez‐Mayen, 田円川原, Thassiana Lacerda Coelho, Gao Zhi-h, Anna Gage, Jiyu Zhang, V. Krčméry	1997	28
8	Resistance Pattern of 2 816 Isolates Isolated from 17 631 Blood Cultures and Etiology of Bacteremia and Fungemia in a Single Cancer Institution Acta Oncologica ·J. Trupl, Laura Milena Porras Nova, E. Oravcová, P. Pichňa, E. Kukučková, Gao Zhi-h, Kevin H. Dunn, Hongshuai Shi, Fazio Massimo, Ph. Canton, Sandra Doherr, Thassiana Lacerda Coelho, 田円川原, Jiyu Zhang, Zhou Qiang	1997	7
9	Staphylococcal bacteremia in cancer patients: Risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia Supportive Care in Cancer ·E. Kukučková, S. Špánik, Amato Rm, بهناز فلک الافلاکی, E. Oravcová, Sandra Doherr, Randall Lea, Gao Zhi-h, Jiyu Zhang, Mohammad Nehal, Mina Araminejad, (unknown), Л.І. Ружинська, A. Kunová, Schmitt Rm, J. Trupl, S Korec, Walter E Rodríguez Romero, V. Krčméry	1996	3
10	Funguria in cancer patients: Analysis of risk factors, clinical presentation and outcome in 50 patients Infection ·E. Oravcová, Л.І. Ружинська, E. Kukučková, V. Krčméry, Sandra Doherr, Ryo Ohsawa, Ľuboš Drgoňa, Yin Ng, Mina Araminejad, Joana Silva, S. Špánik	1996	18
11	Vancomycin plus Imipenem, Ceftazidime or Ciprofloxacin in Second Line Therapy in Patients with Febrile Neutropenia Not Responding to First Line Therapy Chemotherapy ·Sandra Doherr, E. Oravcová, Yin Ng, Л.І. Ружинська, Veronika Bachanová, E. Kukučková, S. Špánik, Jozef Šufliarský, بهناز فلک الافلاکی, J. Trupl, A. Kunová, Chien-Yee C. Cheng, Z Nikbin Dafchahi, Mina Araminejad, V. Krčméry	1996	1
12	Polymicrobial bacteremia in cancer patients: analysis of risk factors, etiology and outcome in 214 episodes International Journal of Antimicrobial Agents ·Amato Rm, P. Pichňa, Walter E Rodríguez Romero, Gao Zhi-h, Randall Lea, E. Oravcová, Jiyu Zhang, Sandra Doherr, Л.І. Ружинська, S. Špánik, A. Kunová, J. Trupl, V. Krčméry	1996	3
13	Bacteremia and Fungemia Occurring during Antimicrobial Prophylaxis with Ofloxacin in Cancer Patients: Risk Factors, Etiology and Outcome Journal of Chemotherapy ·S. Špánik, J. Trupl, Amato Rm, بهناز فلک الافلاکی, Ľuboš Drgoňa, Helena Ruuska, E. Kukučková, Л.І. Ружинська, P. Pichňa, E. Oravcová, Leonardo Perez‐Mayen, Jiyu Zhang, Sandra Doherr, V. Krčméry	1996	3
14	Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. PubMed ·V R Mezhebovsky, J. Trupl, A. Kunová, S. Špánik, Amato Rm, بهناز فلک الافلاکی, Mohammad Nehal, Ľuboš Drgoňa, E. Oravcová, Л.І. Ружинська, Sandra Doherr, Yin Ng, Jiyu Zhang, E. Kukučková, Walter E Rodríguez Romero, Thassiana Lacerda Coelho, Gao Zhi-h, Joyce Cristina dos Santos Reis	1996	8
15	Breakthrough bacteraemic and fungaemic episodes during antimicrobial prophylaxis and therapy in cancer patients: analysis of risk factors, etiology, therapy and outcome in 123 episodes. PubMed ·S. Špánik, V. Krčméry, J. Trupl, Amato Rm, بهناز فلک الافلاکی, Ľuboš Drgoňa, (unknown), Jozef Mardiak, E. Kukučková, Л.І. Ружинська, P. Pichňa, E. Oravcová, Mina Araminejad, Jiyu Zhang, (unknown), Sandra Doherr, Jozef Šufliarský	1996	1
16	Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. PubMed ·V. Krčméry, 初田泰敏, A. Kunová, S. Špánik, Ľuboš Drgoňa, E. Oravcová, Л.І. Ружинська, Sandra Doherr, Yin Ng, Jiyu Zhang, E. Kukučková, Walter E Rodríguez Romero, Thassiana Lacerda Coelho, Gao Zhi-h, Joyce Cristina dos Santos Reis	1996	11
17	<i>Candida</i><i>glabrata</i>, <i>Candida</i><i>krusei</i>, Non-albicans <i>Candida</i> spp., and Other Fungal Organisms in a Sixty-Bed National Cancer Center in 1989-1993: No Association with the Use of Fluconazole Chemotherapy ·A. Kunová, J. Trupl, S. Špánik, Ľuboš Drgoňa, Jozef Šufliarský, Sandra Doherr, Sojung Yune, 勝彦春田, Л.І. Ружинська, E. Kukučková, M. Wynarowicz, P. Pichňa, E. Oravcová, V. Krčméry	1995	23
18	Amphotericin B Lipid Complex to Treat Invasive Fungal Infections in Cancer Patients: Report of Efficacy and Safety in 20 Patients Chemotherapy ·E. Oravcová, Martin Mistrík, Inalda Facincani, Ľuboš Drgoňa, K. von Zembrzuski, بهناز فلک الافلاکی, Amato Rm, A.A-Z. Bytdaeva, S. Špánik, E. Kukučková, V. Krčméry	1995	12
19	Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial. PubMed ·Sojung Yune, Z Nikbin Dafchahi, بهناز فلک الافلاکی, A.A-Z. Bytdaeva, P. Pichňa, Sandra Doherr, 勝彦春田, E. Oravcová, V. Krčméry, C Geniez	1995	5

About E. Oravcová

E. Oravcová is a scholar working on Clinical Biochemistry, Oncology, Infectious Diseases, Pharmacology and Molecular Medicine, having authored 19 papers that have together received 299 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (13 papers), Bacterial Identification and Susceptibility Testing (7 papers), Antifungal resistance and susceptibility (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Fungal Infections and Studies (3 papers), Urinary Tract Infections Management (2 papers), Oral health in cancer treatment (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (21 citations), Infectious Diseases (157 citations), Clinical Biochemistry (53 citations), Molecular Medicine (26 citations) and Epidemiology (146 citations). E. Oravcová has collaborated with scholars based in Slovakia, United States and Malaysia. Frequent co-authors include S. Špánik, J. Trupl, E. Kukučková, V. Krčméry, A. Kunová, Ľuboš Drgoňa, Jozef Šufliarský, P. Pichňa, Jozef Mardiak and L. Ebringer. Their work appears in journals such as Chemotherapy, JAMA Oncology, Journal of Clinical Oncology, Infection and Journal of Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact